Adiponectin and peak bone mass in men: a cross-sectional, population-based study

Area of Science:

• Endocrinology
• Bone Biology
• Metabolic Health

Background:

• Adiponectin, a hormone secreted by adipocytes and bone cells, plays a role in metabolic regulation.
• Previous research on the association between serum adiponectin and bone mineral density (BMD) has yielded conflicting results.
• Understanding this relationship is crucial, especially during peak bone mass acquisition.

Purpose of the Study:

• To investigate the association between serum adiponectin levels and BMD in young, healthy men at peak bone mass.
• To explore potential correlations between adiponectin and specific bone parameters, including femoral bone marrow size.

Main Methods:

• A population-based cross-sectional study involving 700 healthy men aged 20-29 years.
• Measurement of BMD at the femoral neck, total hip, and lumbar spine.
• Magnetic resonance imaging (MRI) to assess femoral cortical thickness and bone marrow size in a subsample (n=363).
• Regression analyses were employed to examine associations, adjusting for confounding variables.

Main Results:

• An inverse association was observed between serum adiponectin and total hip BMD (r = -0.092; P = 0.036).
• A direct association was found between serum adiponectin and femoral bone marrow size (r = 0.164; P = 0.003).
• Femoral muscle size potentially mediates the relationship between adiponectin and total hip BMD.

Conclusions:

• Serum adiponectin is inversely associated with total hip BMD in young men at peak bone mass.
• The observed association with total hip BMD may be influenced by muscle size and function.
• The link between adiponectin and femoral bone marrow size remains significant even after covariate adjustment.